246 related articles for article (PubMed ID: 30007991)
21. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
22. MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.
Dong X; Ding W; Ye J; Yan D; Xue F; Xu L; Yin J; Guo W
Cell Biochem Funct; 2016 Oct; 34(7):491-496. PubMed ID: 27650047
[TBL] [Abstract][Full Text] [Related]
23. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
[TBL] [Abstract][Full Text] [Related]
24. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
World J Gastroenterol; 2012 Oct; 18(38):5442-53. PubMed ID: 23082062
[TBL] [Abstract][Full Text] [Related]
25. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
Huang XH; Chen JS; Wang Q; Chen XL; Wen L; Chen LZ; Bi J; Zhang LJ; Su Q; Zeng WT
J Pathol; 2011 Nov; 225(3):463-72. PubMed ID: 21671467
[TBL] [Abstract][Full Text] [Related]
26. miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8.
Yin T; Liu MM; Jin RT; Kong J; Wang SH; Sun WB
Pathol Res Pract; 2019 Jun; 215(6):152406. PubMed ID: 30967300
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
28. Long non‑coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT‑PCR and meta‑analysis of 393 cases.
Zhang Y; Huang JC; Cai KT; Yu XB; Chen YR; Pan WY; He ZL; Lv J; Feng ZB; Chen G
Int J Oncol; 2017 Dec; 51(6):1705-1721. PubMed ID: 29039502
[TBL] [Abstract][Full Text] [Related]
29. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
30. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma.
Zhu B; Gu S; Wu X; He W; Zhou H
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34806748
[TBL] [Abstract][Full Text] [Related]
32. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
Zhang CJ; Du HJ
Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
He RQ; Yang X; Liang L; Chen G; Ma J
Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
[TBL] [Abstract][Full Text] [Related]
34. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.
Tang Q; Wang Q; Zhang Q; Lin SY; Zhu Y; Yang X; Guo AY
BMC Cancer; 2017 Dec; 17(1):862. PubMed ID: 29254483
[TBL] [Abstract][Full Text] [Related]
35. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
36. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
37. Microarray‑based bioinformatics analysis of the prospective target gene network of key miRNAs influenced by long non‑coding RNA PVT1 in HCC.
Zhang Y; Mo WJ; Wang X; Zhang TT; Qin Y; Wang HL; Chen G; Wei DM; Dang YW
Oncol Rep; 2018 Jul; 40(1):226-240. PubMed ID: 29749550
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA ZFAS1 promotes hepatocellular carcinoma proliferation by epigenetically repressing miR-193a-3p.
Zhou HL; Zhou YF; Feng ZT
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9840-9847. PubMed ID: 31799651
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.
Liang HW; Ye ZH; Yin SY; Mo WJ; Wang HL; Zhao JC; Liang GM; Feng ZB; Chen G; Luo DZ
Onco Targets Ther; 2017; 10():3405-3419. PubMed ID: 28744145
[TBL] [Abstract][Full Text] [Related]
40. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
